Patient-reported outcomes in a pilot clinical trial of twice-weekly hemodialysis start with adjuvant pharmacotherapy and transition to thrice-weekly hemodialysis vs conventional hemodialysis

HIGHLIGHTS

• who: Mariana Murea from the Department of Internal Medicine, Section on Nephrology, Wake Forest, u20111053, USA have published the article: Patient-reported outcomes in a pilot clinical trial of twice-weekly hemodialysis start with adjuvant pharmacotherapy and transition to thrice-weekly hemodialysis vs conventional hemodialysis, in the Journal: (JOURNAL) of June/14,/2019
• what: The TWOPLUS Pilot study was an individually-randomized trial conducted at 14 dialysis units with the primary goal to assess feasibility and safety. In spite of the alluring attributes of incremental HD rendered by other potential benefits such as better or . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.